Revolutionizing Pulmonary Medicine
Advancing Terpene-API Development
Pulmonara Labs' core focus is based on Terpene-API Development, to establish regulated therapeutic treatments - creating a safer alternative to conventional consumption methods. There is clear potential in developing new therapeutic treatments, offering a compelling and safer alternative to the conventional consumption methods prevalent in the pharmaceutical industry.
There is significant scientific evidence to support plant-derived therapeutic interventions can provide significant quality-of-life adjustments for individuals suffering from these diseases, while also serving as an alternative to steroid-based treatment options. Most treatments for respiratory diseases are oral drug delivery systems, whereas this product delivers therapeutic agents at the site of the disease.
Unlocking Therapeutic Benefit Through Plant Based Medicines
Future drug product analogs developed from plant-derived terpenes can be used to induce extensive therapeutic benefits. The potential for definitive strategies targeting distinct underlying conditions grow in proportion to the rate they are being studied and developed. Additional chemical modifications to already existing plant-derived terpenes can offer access to different biochemical targeting pathways aside from conventional pathways.
Pharma. Sector Quality Systems
Furthering the advancement and validation of new and emerging plant derivative drug products under current FDA Regulations for Drug Product R&D, Manufacturing and Testing.
Reliable Research and Development
Finding links between pharmaceutical grade plant derivatives and its ability to be applied as a treatment method for orphan respiratory diseases.
Infiltration & Disruption of Major Drug Product Markets
Market Evaluations spanning billions of dollars across domestic and global markets for each analog product.
How We Got Here
Pulmonara Labs began as a pioneering company based in Philadelphia dedicated to making a profound impact on healthcare through innovative plant-derived terpene research. With a strong commitment to addressing orphan diseases, Pulmonara Labs combines cutting-edge science and the therapeutic potential of plant-derived terpenes to develop groundbreaking solutions. Our mission is not only to advance medical knowledge but also to improve the lives of those suffering from rare and overlooked conditions. Through relentless dedication and a focus on scientific excellence, Pulmonara Labs is at the forefront of redefining the boundaries of plant-derived terpene research.
Where We're Going
The future of Pulmonara Labs holds great promise and potential. As the field of terpene research continues to evolve and gain acceptance, the company is poised to play a pivotal role in advancing the use of terpene-based treatments for orphan diseases. With ongoing research and development, we aim to bring innovative therapies to market, offering hope to patients who have long been underserved by traditional medicine.
Pulmonara Labs recently partnered with Saint Joseph's University to set up a new and exciting incubator program.
Collaborative efforts with students and faculty at Saint Joseph's University has yielded promising results for our company and its relationship with the Philadelphia community.